Welch Allyn Establishes New Regional Headquarters, Operations Center in The Netherlands

Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient safety and outcomes, today announced the official establishment of its Europe, Middle East & Indian Sub-Continent (EMEI) headquarters and a consolidated Operations Center in the Netherlands. Both sites are part of the company's current realignment strategy aimed at positioning Welch Allyn for future growth throughout the region.

"In order to achieve our full potential in this part of the world, we made the tactical decision to realign our resources to best meet the challenges and opportunities of a rapidly changing global healthcare environment, while at the same time offering greater accessibility to our customers in 45 countries throughout Europe, the Middle East and the Indian Sub-Continent," said Steve Meyer, Welch Allyn president and CEO. "The Netherlands was a logical choice to locate, as it offers Welch Allyn a favorable business and tax climate, excellent physical and telecommunications resources, and a world-class transportation infrastructure that provides direct access to our regional leadership and our customers."

The Welch Allyn EMEI headquarters is located in the city of Leiden, just outside Amsterdam. Known as the heart of the country's economic center, Leiden is home to many U.S. and international headquarters, a bioscience park and both Leiden University and its affiliated medical center. Situated in Le Carrefour Complex, the Welch Allyn EMEI headquarters will include a state-of-the-art sales and product training center for internal, distributor and customer training, as well as a Customer Experience Center, which will showcase the company's history, culture and products.

"We are very pleased to welcome Welch Allyn's EMEI headquarters and Operations Center to the Netherlands," says Henny Jacobs, Director Investment Projects at the Netherlands Foreign Investment Agency (NFIA) headquarters in The Hague. "We are proud to have worked closely with the Welch Allyn team supporting the decision making process and realization of these projects, together with our partners Holland International Distribution Council and BOM Foreign Investment, on the Operations Center, and both WestHolland Foreign Investment Agency and the City of Leiden on the headquarters."

The Welch Allyn Operations Center is located approximately one hour from the EMEI headquarters in the city of Tilburg. Through a strategic partnership, Welch Allyn has co-located its warehouse and distribution, product repair, technical support and product configuration activities to a leased space at Rhenus Logistics, a worldwide transport and logistics company. This site will focus on product repair, technical support and product configuration, while allowing Rhenus Logistics to manage warehouse and distribution functions for Welch Allyn. This unique agreement will allow Welch Allyn to optimize its supply chain throughout Europe, the Middle East and the Indian Sub-Continent by improving operational excellence, and more efficiently serving customers throughout the region. The partnership will be phased in through early 2014.

"This is an exciting time for Welch Allyn, and the opening of our new EMEI Headquarters and Operations Center in the Netherlands is an important step in furthering our goals and streamlining our business practices in key markets throughout the region," said Hisham Hout, senior vice president, EMEI at Welch Allyn. "Already the response has been extremely positive, and we look forward to furthering the Welch Allyn brand by bringing the best possible solutions to our customers throughout Europe, the Middle East and the Indian Sub-Continent."

"We are confident that having a regional headquarters and consolidated logistics center in The Netherlands will be of great benefit in driving our business forward throughout the region," said Jon Soderberg, executive vice president and chief corporate development officer at Welch Allyn. "This is an exciting time in EMEI, and we are very optimistic about the potential that exists here, which is certain to be beneficial to Welch Allyn, our business partners and the customers we serve."

About Welch Allyn
Welch Allyn helps reduce risk and improve patient safety, satisfaction and outcomes in a variety of clinical settings through a complete range of EMR-interfaced vital signs and cardiac monitoring diagnostic solutions, physical diagnosis instruments, and infection control products. The company specializes in helping doctors, nurses and other frontline providers across the globe streamline workflow by developing innovative solutions that enable immediate access to accurate patient data. A leading global healthcare company founded in 1915 and headquartered in Skaneateles Falls, N.Y. (USA), Welch Allyn is a family-owned business that employs nearly 2,600 employees in 26 different countries.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...